Product Name FSC Fondaparinux intermediate N-3
CAS Number 114903-05-8
Formula C31H53N3O49S4
Molar Mass 1728.27 g/mol
Pub Chem CID 11560131
Drug Bank DB13317
Chem Spider 9738611
Bioavailability Not Available
Protein Binding 94%
Metabolism Not Available
Elimination Halflife 17-21 hours
FAQ
What is FSC Fondaparinux intermediate N-3 and how does it work in the body?

FSC Fondaparinux intermediate N-3 is a medication used to prevent blood clots in patients who are undergoing certain types of surgeries or who have a medical condition that puts them at a higher risk of developing blood clots. It works by inhibiting the activity of a specific clotting factor in the blood, reducing the risk of clot formation.

How is FSC Fondaparinux intermediate N-3 administered and what is the recommended dosage?

FSC Fondaparinux intermediate N-3 is typically administered as an injection under the skin (subcutaneous injection). The recommended dosage and frequency of administration will vary depending on the specific medical condition being treated and the individual patient's needs. It is important to follow the dosing instructions provided by your healthcare provider.

What are the possible side effects of FSC Fondaparinux intermediate N-3?

Like all medications, FSC Fondaparinux intermediate N-3 can cause side effects. Common side effects may include bruising or bleeding at the injection site, minor irritation or itching, and mild discomfort. In rare cases, more serious side effects such as allergic reactions or severe bleeding may occur. If you experience any concerning symptoms after taking this medication, contact your healthcare provider immediately.

Who should not take FSC Fondaparinux intermediate N-3?

FSC Fondaparinux intermediate N-3 may not be suitable for everyone. Patients with a history of bleeding disorders, kidney disease, or certain types of heart conditions may be at a higher risk of experiencing complications from this medication. Additionally, individuals who are pregnant or breastfeeding should consult with their healthcare provider before taking FSC Fondaparinux intermediate N-3. It is essential to disclose your full medical history and all current medications to your healthcare provider before starting this treatment.

How can I obtain more information about FSC Fondaparinux intermediate N-3 and its use?

For more information about FSC Fondaparinux intermediate N-3, including detailed dosing instructions, possible side effects, and important safety information, speak with your healthcare provider or pharmacist. They can provide you with personalized guidance based on your individual health needs and help you determine if this medication is right for you.
Back
Become a customer
If you have any questions about our products and services, please contact us at 0086-25-52397803 or mail to info@fidaxomicin-ascomycin.com.
We will reply to you as soon as possible.
Get a quick quote
Click For Help
Leave A Message
Leave A Message ×
If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.